Intravascular adenosine at reperfusion reduces infarct size and neutrophil adherence

Annals of Thoracic Surgery

Volumn 62, Issue 5, 1996, Pages 1364-1372

  Todd, James ^a   Zhao, Zhi Qing ^a   Williams, Mark W ^a   Sato, Hiroki ^a   Van Wylen, David G L ^a   Vinten Johansen, Jakob ^a,b  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

8 (2 NOR 1 ADAMANTYL) 1,3 DIPROPYLXANTHINE; 8 (4 SULFOPHENYL)THEOPHYLLINE; ADENOSINE; POLYADENYLIC ACID; XANTHINE DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL ADHESION; CONTROLLED STUDY; HEART INFARCTION; HEART INFARCTION SIZE; HEART PROTECTION; INTRAVENOUS DRUG ADMINISTRATION; MALE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; RABBIT; REPERFUSION INJURY;

EID: 0030296470     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/0003-4975(96)00495-X     Document Type: Article

References (25)

1. 1. Mullane K, Bullough D. Harnessing an endogenous cardioprotective mechanism: cellular sources and sites of action of adenosine. J Mol Cell Cardiol 1994;27:1041-54.
2. 2. Lasley RD, Mentzer RM Jr. Protective effects of adenosine in the reversibly injured heart. Ann Thorac Surg 1995;60:843-6.
3. 3. Hudspeth DA, Nakanishi K, Vinten-Johansen J, et al. Adenosine in blood cardioplegia prevents postischemic dysfunction in ischemically injured hearts. Ann Thorac Surg 1994;58: 1637-44.
4. 1 adenosine receptors in rabbit hearts. Circulation 1991;84:350-6.
5. 1 receptor mediated protection of the globally ischemic isolated rat heart. J Mol Cell Cardiol 1990;22:39-47.
6. 6. Mentzer RM Jr, Bunger R, Lasley RD. Adenosine enhanced preservation of myocardial function and energetics. Possible involvement of the adenosine A1 receptor system. Cardiovasc Res 1993;27:28-35.
7. 7. Randhawa MPS Jr, Lasley RD, Mentzer RM Jr. Salutary effects of exogenous adenosine administration on in vivo myocardial stunning. J Thorac Cardiovasc Surg 1995;110: 63-74.
8. 8. Zhao Z-Q, McGee DS, Nakanishi K, et al. Receptor-mediated cardioprotective effects of endogenous adenosine are exerted primarily during reperfusion after coronary occlusion in the rabbit. Circulation 1993;88:709-19.
9. 1-receptor-mediated infarct size reduction by endogenous adenosine is exerted primarily during myocardial ischemia. FASEB J 1993;7:A419.
10. 10. Vinten-Johansen J, Zhao Z-Q. Cardioprotection from ischemic-reperfusion injury by adenosine. In: Abd-Elfattah AS, Wechsler AS, eds. Purines and mycardial protection. Boston: Kluwer Academic Publishers, 1995:315-44.
11. 11. Cronstein BN, Levin RI, Belanoff J, Weissmann G, Hirschhorn R. Adenosine: an endogenous inhibitor of neutrophil-mediated injury to endothelial cells. J Clin Invest 1986;78: 760-70.
12. 12. Cronstein BN, Kramer SB, Weissmann G, Hirschhorn R. Adenosine: a physiological modulator of superoxide anion generation by human neutrophils. J Exp Med 1983;158: 1160-77.
13. 13. Dreyer WJ, Michael LH, West MW, et al. Neutrophil accumulation in ischemic canine myocardium: insights into time course, distribution, and mechanism of localization during early reperfusion. Circulation 1991;84:400-11.
14. 14. Lefer AM, Tsao PS, Lefer DJ, Ma X. Role of endothelial dysfunction in the pathogenesis of reperfusion injury after myocardial ischemia. FASEB J 1991;5:2029-34.
15. 1-receptor mediated myocardial infarct size reduction by endogenous adenosine is exerted primarily during ischaemia. Cardiovasc Res 1994;28:270-9.
16. 16. Doerschuk CM, Allard MF, Hogg JC. Neutrophil kinetics in rabbits during infusion of zymosan-activated plasma. J Appl Physiol 1989;67:88-95.
17. 17. Sato H, Zhao Z-Q, Vinten-Johansen J. L-arginine inhibits neutrophil adherence and coronary artery dysfunction. Cardiovasc Res 1996;31:63-72.
18. 18. Van Wylen DGL, Willis J, Sodhi J, Weiss RJ, Lasley RD, Mentzer RM Jr. Cardiac microdialysis to estimate interstitial adenosine and coronary blood flow. Am J Physiol 1990;258: H1642-9.
19. 19. Zhao Z-Q, Williams MW, Sato H, et al. Acadesine reduces myocardial infarct size by an adenosine mediated mechanism. Cardiovasc Res 1995;29:495-505.
20. 20. Schrader J, Nees S, Gerlach E. Evidence for a cell surface adenosine receptor on coronary myocytes and atrial muscle cells: studies with an adenosine derivative of high molecular weight. Pflug Archiv 1977;369:251-7.
21. 21. Toombs CF, McGee DS, Johnston WE, Vinten-Johansen J. Myocardial protective effects of adenosine. Infarct size reduction with pretreatment and continued receptor stimulation during ischemia. Circulation 1992;86:986-94.
22. 22. Mehta JL, Nichols WW, Mehta P. Neutrophils as potential participants in acute myocardial ischemia: relevance to reperfusion. J Am Coll Cardiol 1988;11:1309-16.
23. 23. Gunther GR, Herring MB. Inhibition of neutrophil superoxide production by adenosine released from vascular endothelial cells. Ann Vasc Surg 1991;5:325-30.
24. 2-receptor activation inhibits neutrophil-mediated injury to coronary endothelium by attenuating superoxide radical generation and adherence. Am J Physiol (in press). .
25. 25. Smolenski RT, Kochan Z, McDouall R, Page C, Seymour AL, Yacoub MH. Endothelial nucleotide catabolism and adenosine production. Cardiovasc Res 1994;28:100-4.